Showing 1701-1710 of 5790 results for "".
PROLITE III, IPL System by Quantel Derma
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/prolite-iii-ipl-system-by-quantel-derma/19374/PROLITE III by Quantel Derma - The Right Choice for the Right Pulse. The powerful intense pulsed light system (IPL) - high-speed treatments for photo rejuvenation and permanent hair removal. An effective contact cooling is integrated in the handpieces. A variable pulse formation makes PROLITE III exBotox Cosmetic Patient Perceptions
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/botox-cosmetic-patient-perceptions/19382/Results of a survey by Allergan and Healthy Women reveal changing perceptions about treatment with the neurotoxin. Featuring Courtney Thorne-Smith.Telltale Hands
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/telltale-hands/19400/Dr. Amy Derick reviews ways to rejuvenate the hands through lasers, fillers and topical prescription creams.Dr. Chan Discusses Experience with Gemini Laser
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/dr-chan-discusses-experience-with-gemini-laser/19471/“Gemini is an extremely effective non-ablative skin rejuvenation laser. And by combining the 532 KTP lasers with the long pulse 1064 YAG, we can achieve non-ablative skin rejuvenations in terms of reductions of pigmentations, fine lines, pore size and vessel improvement.” & #8212Professor HenrySclerotherapy - Part 3
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/sclerotherapy-part-3/19500/This is the third video in a series of four.Journal Club: Dupilumab and Atopic March
https://practicaldermatology.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-dupilumab-and-atopic-march/32405/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, and Editorial Board member Peter Lio, MD, discuss recent research indicating a reduced risk of atopic march in pediatric atopic dermatitis patients on dupilumab.Lin TL, Fan YH, Fan KS, Juan CK, Chen YJ, Wu CY. ReducedLeadership Without Authority:Influencers of Culture in Your Practice
https://practicaldermatology.com/issues/may-june-2025/leadership-without-authority-influencers-of-culture-in-your-practice/35924/Influencers in popular culture demonstrate how individuals without formal authority can shape trends, ideas, and behavior.Harnessing AI for Dermatology Residents
https://practicaldermatology.com/issues/may-june-2025/harnessing-ai-for-dermatology-residents/35915/Dermatology residents face the dual challenge of delivering high-quality patient care while continually advancing their medical knowledge and research skills.Vitiligo Update: Pathogenesis, Therapies, and Integrative Approaches
https://practicaldermatology.com/issues/may-june-2025/vitiligo-update-pathogenesis-therapies-and-integrative-approaches/35920/Vitiligo is a chronic autoimmune condition characterized by depigmented white patches due to melanocyte destruction, attributed to genetic factors and environmental triggers.DWTV Extra: Phase 3 Data on Roflumilast for AD, PsO
https://practicaldermatology.com/series/dermwire-tv/dwtv-extra-phase-3-data-on-roflumilast-for-ad-pso/35925/Study investigator Melinda Gooderham, MD, talks about the Phase 3 trials of roflumilast cream 0.15% for adults and children down to age 6 with atopic dermatitis and roflumilast foam 0.3% for patients older than 12 with psoriasis of the scalp and body.